Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petros Efthimiou

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Seminars in Arthritis and Rheumatism|September 15, 2006
Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implicationsPetros Efthimiou
Seminars in Arthritis and Rheumatism|September 5, 2006
Pathogenesis and management of adult-onset Still's diseasePetros Efthimiou, Sharon Georgy
Annals of the Rheumatic Diseases|November 28, 2006
QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?Petros Efthimiou, Sunita Sood
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2010
Headache from cavernous sinus thrombosis in Adamantiades-Behçet diseasePetros Efthimiou, Olga Petryna
Biomed Research International|July 19, 2016
Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?Sujani Yadlapati, Petros Efthimiou
Seminars in Arthritis and Rheumatism|April 20, 2012
The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's diseaseApostolos Kontzias, Petros Efthimiou
The Journal of Rheumatology|March 3, 2012
Radiographic improvement in sarcoid arthropathy after infliximab treatmentBella Mehta, Petros Efthimiou
International Journal of Inflammation|April 27, 2012
Ferritin in adult-onset still's disease: just a useful innocent bystander?Bella Mehta, Petros Efthimiou
Annals of Medicine|January 24, 2015
Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment optionsSabeeda Kadavath, Petros Efthimiou
Rheumatology International|October 31, 2009
Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalitiesPetros Efthimiou, Manil Kukar
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Seminars in Arthritis and Rheumatism|September 15, 2006
Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implicationsPetros Efthimiou
Seminars in Arthritis and Rheumatism|September 5, 2006
Pathogenesis and management of adult-onset Still's diseasePetros Efthimiou, Sharon Georgy
Annals of the Rheumatic Diseases|November 28, 2006
QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?Petros Efthimiou, Sunita Sood
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2010
Headache from cavernous sinus thrombosis in Adamantiades-Behçet diseasePetros Efthimiou, Olga Petryna
Biomed Research International|July 19, 2016
Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?Sujani Yadlapati, Petros Efthimiou
Seminars in Arthritis and Rheumatism|April 20, 2012
The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's diseaseApostolos Kontzias, Petros Efthimiou
The Journal of Rheumatology|March 3, 2012
Radiographic improvement in sarcoid arthropathy after infliximab treatmentBella Mehta, Petros Efthimiou
International Journal of Inflammation|April 27, 2012
Ferritin in adult-onset still's disease: just a useful innocent bystander?Bella Mehta, Petros Efthimiou
Annals of Medicine|January 24, 2015
Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment optionsSabeeda Kadavath, Petros Efthimiou
Rheumatology International|October 31, 2009
Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalitiesPetros Efthimiou, Manil Kukar
Pageof 5